2cureX AB
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
2CUREX | ST
Overview
Corporate Details
- ISIN(s):
- SE0010468124
- LEI:
- 549300SFOL75WIYF2O80
- Country:
- Sweden
- Address:
- Box 159, 261 22 Landskrona
- Website:
- https://www.2curex.com/
Description
2cureX AB is a company specializing in functional precision oncology, dedicated to improving cancer treatment outcomes. The company develops and commercializes the IndiTreat® test, a CE-marked in vitro diagnostic (IVD) tool that predicts individual patient response to cancer therapies. The IndiTreat® technology uses 3D tumoroids, or micro-tumors, grown from a patient's own biopsy. These tumoroids are then tested against various cancer drugs to identify the most effective treatment option before it is administered to the patient. This approach provides oncologists with personalized data to guide therapy selection, with an initial focus on patients with advanced cancers like metastatic colorectal cancer. By directly measuring drug sensitivity, 2cureX aims to provide a higher level of precision in personalized medicine.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all 2cureX AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for 2cureX AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for 2cureX AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
